> top > docs > PubMed:26930132 > annotations

PubMed:26930132 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-43 Sentence denotes Preeclampsia and superimposed preeclampsia:
TextSentencer_T2 44-61 Sentence denotes The same disease?
TextSentencer_T3 62-96 Sentence denotes The role of angiogenic biomarkers.
TextSentencer_T4 97-107 Sentence denotes OBJECTIVE:
TextSentencer_T5 108-326 Sentence denotes We aimed to compare sFlt-1 and placental growth factor (PlGF) levels and the sFlt-1/PlGF ratio between women with preeclampsia and superimposed preeclampsia to, respectively, normotensive and chronic hypertensive ones.
TextSentencer_T6 327-340 Sentence denotes STUDY DESIGN:
TextSentencer_T7 341-508 Sentence denotes We performed a prospective two-armed cohort in a tertiary teaching hospital in Sao Paulo, Brazil, including 37 normotensive and 60 chronic hypertensive pregnant women.
TextSentencer_T8 509-634 Sentence denotes We assessed the serum levels of sFlt-1 and PlGF at 20, 26, 32, and 36 gestational weeks by enzyme-linked immunosorbent assay.
TextSentencer_T9 635-657 Sentence denotes MAIN OUTCOME MEASURES:
TextSentencer_T10 658-708 Sentence denotes Having preeclampsia and superimposed preeclampsia.
TextSentencer_T11 709-717 Sentence denotes RESULTS:
TextSentencer_T12 718-873 Sentence denotes Among normotensive and chronic hypertensive pregnancies, 4 (10.8%) and 14 (23.3%) women developed preeclampsia and superimposed preeclampsia, respectively.
TextSentencer_T13 874-1378 Sentence denotes Compared with those who remained normotensive, the preeclampsia women presented higher sFlt-1 levels at 32 gestational weeks (4323.45 pg/mL vs. 2242.04 pg/mL, p = 0.019), lower PlGF levels at 20 (183.54 pg/mL vs. 337.38 pg/mL, p = 0.034), 32 (169.69 pg/mL vs. 792.53 pg/mL, p = 0.001), and 36 gestational weeks (252.99 pg/mL vs. 561.81 pg/mL, p = 0.029), and higher sFlt-1/PlGF ratios at 26 (9.02 vs. 1.84, p = 0.004), 32 (23.61 vs. 2.55, p = 0.001), and 36 gestational weeks (49.02 vs. 7.34, p = 0.029).
TextSentencer_T14 1379-1582 Sentence denotes On the other hand, compared with those who remained chronic hypertensive, the superimposed preeclampsia women only presented a higher sFlt-1/PlGF ratio at 32 gestational weeks (9.98 vs. 2.51, p = 0.039).
TextSentencer_T15 1583-1594 Sentence denotes CONCLUSION:
TextSentencer_T16 1595-1781 Sentence denotes Although angiogenic imbalance is clearly related to preeclampsia, it seems to play a more modest role in superimposed preeclampsia, in which other mechanisms should also be investigated.
T1 0-43 Sentence denotes Preeclampsia and superimposed preeclampsia:
T2 44-61 Sentence denotes The same disease?
T3 62-96 Sentence denotes The role of angiogenic biomarkers.
T4 97-107 Sentence denotes OBJECTIVE:
T5 108-326 Sentence denotes We aimed to compare sFlt-1 and placental growth factor (PlGF) levels and the sFlt-1/PlGF ratio between women with preeclampsia and superimposed preeclampsia to, respectively, normotensive and chronic hypertensive ones.
T6 327-340 Sentence denotes STUDY DESIGN:
T7 341-508 Sentence denotes We performed a prospective two-armed cohort in a tertiary teaching hospital in Sao Paulo, Brazil, including 37 normotensive and 60 chronic hypertensive pregnant women.
T8 509-634 Sentence denotes We assessed the serum levels of sFlt-1 and PlGF at 20, 26, 32, and 36 gestational weeks by enzyme-linked immunosorbent assay.
T9 635-657 Sentence denotes MAIN OUTCOME MEASURES:
T10 658-708 Sentence denotes Having preeclampsia and superimposed preeclampsia.
T11 709-717 Sentence denotes RESULTS:
T12 718-873 Sentence denotes Among normotensive and chronic hypertensive pregnancies, 4 (10.8%) and 14 (23.3%) women developed preeclampsia and superimposed preeclampsia, respectively.
T13 874-1378 Sentence denotes Compared with those who remained normotensive, the preeclampsia women presented higher sFlt-1 levels at 32 gestational weeks (4323.45 pg/mL vs. 2242.04 pg/mL, p = 0.019), lower PlGF levels at 20 (183.54 pg/mL vs. 337.38 pg/mL, p = 0.034), 32 (169.69 pg/mL vs. 792.53 pg/mL, p = 0.001), and 36 gestational weeks (252.99 pg/mL vs. 561.81 pg/mL, p = 0.029), and higher sFlt-1/PlGF ratios at 26 (9.02 vs. 1.84, p = 0.004), 32 (23.61 vs. 2.55, p = 0.001), and 36 gestational weeks (49.02 vs. 7.34, p = 0.029).
T14 1379-1582 Sentence denotes On the other hand, compared with those who remained chronic hypertensive, the superimposed preeclampsia women only presented a higher sFlt-1/PlGF ratio at 32 gestational weeks (9.98 vs. 2.51, p = 0.039).
T15 1583-1594 Sentence denotes CONCLUSION:
T16 1595-1781 Sentence denotes Although angiogenic imbalance is clearly related to preeclampsia, it seems to play a more modest role in superimposed preeclampsia, in which other mechanisms should also be investigated.

Preeclampsia

Id Subject Object Predicate Lexical cue
PD-Preeclampsia-B_T1 0-12 ORPHA:275555 denotes Preeclampsia
PD-Preeclampsia-B_T2 30-42 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T3 222-234 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T4 252-264 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T5 665-677 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T6 695-707 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T7 816-828 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T8 846-858 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T9 925-937 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T10 1470-1482 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T11 1647-1659 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T12 1713-1725 ORPHA:275555 denotes preeclampsia

Preeclampsia-compare

Id Subject Object Predicate Lexical cue
PD-Preeclampsia-B_T1 0-12 ORPHA:275555 denotes Preeclampsia
PD-Preeclampsia-B_T2 30-42 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T3 222-234 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T4 252-264 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T5 665-677 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T6 695-707 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T7 816-828 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T8 846-858 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T9 925-937 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T10 1470-1482 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T11 1647-1659 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T12 1713-1725 ORPHA:275555 denotes preeclampsia

preeclampsia_genes

Id Subject Object Predicate Lexical cue
PD-PreeclampsiaGenes-B_T1 139-162 HGNC:PGF denotes placental growth factor

UBERON-AE

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 372-377 http://purl.obolibrary.org/obo/UBERON_0001460 denotes armed
PD-UBERON-AE-B_T2 525-530 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 525-530 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
PD-UBERON-AE-B_T2 139-148 http://purl.obolibrary.org/obo/UBERON_0001987 denotes placental
PD-UBERON-AE-B_T3 372-377 http://purl.obolibrary.org/obo/UBERON_0001460 denotes armed